Holen Sie sich die Stockscreener-App
5.82
1.39%
0.08
Vorhandelsmarkt:
5.81
-0.01
-0.17%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$5.74
Offen:
$5.77
24-Stunden-Volumen:
838.73K
Relative Volume:
0.42
Marktkapitalisierung:
$2.17B
Einnahmen:
$10.27B
Nettoeinkommen (Verlust:
$120.00M
KGV:
14.05
EPS:
0.4142
Netto-Cashflow:
$949.99M
1W Leistung:
+7.98%
1M Leistung:
+15.71%
6M Leistung:
-3.16%
1J Leistung:
+29.33%
1-Tages-Spanne:
$5.73
$5.86
1-Wochen-Bereich:
$5.41
$5.86
52-Wochen-Spanne:
$4.41
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
5.82 | 2.14B | 10.27B | 120.00M | 949.99M | 0.4142 |
TAK
Takeda Pharmaceutical Co Adr
|
17.78 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
119.04 | 50.78B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.59 | 43.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.26 | 36.81B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
580.51 | 25.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Bausch Health rises after $300M worth insider purchase (update) - MSN
What makes Bausch Health (BHC) appear so attractive - MSN
Bausch Health Companies Inc. and Ortho Dermatologics Announces Launch Of Biafine Skin Recovery Emulsion Through Convenient Online Ordering - marketscreener.com
Bausch Health launches Biafine skincare emulsion online in U.S. By Investing.com - Investing.com Australia
Bausch Health launches Biafine skincare emulsion online in U.S. - Investing.com
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering - marketscreener.com
French skin cream sold since 1971 is now available online in the U.S. - Stock Titan
Patterns Watch: Can Bausch Health Companies Inc expand into new markets - baoquankhu1.vn
Market Wrap: Is Bausch Health Companies Inc subject to activist investor interestWeekly Trend Summary & Precise Swing Trade Alerts - baoquankhu1.vn
Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand - GlobeNewswire Inc.
Forecast Cut: Will Bausch Health Companies Inc announce a stock splitWeekly Market Outlook & Real-Time Market Sentiment Reports - baoquankhu1.vn
Earnings Update: How does Bausch Health Companies Inc perform in inflationary periods2026 Snapshot & Low Risk High Win Rate Picks - baoquankhu1.vn
US Market Recap: Is Bausch Health Companies Inc likely to announce a buybackQuarterly Profit Review & Accurate Entry/Exit Alerts - baoquankhu1.vn
Analyst Downgrade: Whats the outlook for Bausch Health Companies Incs sectorBreakout Watch & Weekly Top Gainers Trade List - baoquankhu1.vn
Global Keloid Treatment Market Outlook | North America, Asia Pacific, Europe Lead | Bausch Health, Sciton, Galderma Drive Multi-Modal Dermatology Innovation - Morningstar
JPMorgan Chase & Co. Sells 242,608 Shares of Bausch Health Cos Inc. $BHC - MarketBeat
Street Watch: Is Bausch Health Companies Inc subject to activist investor interest2026 Sentiment & Stock Portfolio Risk Control - baoquankhu1.vn
Bausch Health Releases Additional Proxy Materials - National Today
[ARS] Bausch Health Companies Inc. SEC Filing - Stock Titan
Bausch Health (NYSE: BHC) outlines 2026 virtual meeting, board slate and say-on-pay vote - Stock Titan
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update – Company AnnouncementFT.com - Financial Times
Bausch Health Companies Inc. (BHC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Treasury Yields: Does Bausch Health Companies Inc have a sustainable dividend2026 Price Swings & Weekly Market Pulse Alerts - baoquankhu1.vn
Bausch reaches deal with competitor over IBS drug generic - Life Sciences Intellectual Property Review
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe - Financial Times
Bausch Health Companies (TSE:BHC) Trading Up 0.3%Should You Buy? - MarketBeat
Bausch, MSN Laboratories Settle Patent Battle Over IBS Drug - Law360
Aug Movers: Can Bausch Health Companies Inc beat the S P 5002026 Pullbacks & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Bausch Health (NYSE: BHC) director receives 5,946 RSUs for board service - Stock Titan
John Paulson receives 11,574 Bausch Health (NYSE: BHC) RSUs as fees - Stock Titan
[Form 4] Bausch Health Companies Inc. Insider Trading Activity - Stock Titan
Bausch Health Companies Inc. (BHC.TO) stock price, news, quote and history - Yahoo Finance UK
Bausch Health to Announce First Quarter 2026 Results on April 29 - GuruFocus
List of 22 Acquisitions by Bausch Health (Apr 2026) - Tracxn
BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth - Eastern Progress
What Makes Bausch Health (BHC) Appear So Attractive - Insider Monkey
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 - Bitget
Bausch Health (BHC) Climbs 45% on Insider Buying - MSN
Nasdaq Moves: Can Bausch Health Companies Inc beat the S P 500Trade Analysis Summary & Community Verified Trade Signals - baoquankhu1.vn
Trend Report: What is Bausch Health Companies Incs valuation compared to sectorQuarterly Profit Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program - Bioscience Association Manitoba
Death Cross: Can Bausch Health Companies Inc beat the S P 5002026 Growth vs Value & Real-Time Buy Signal Notifications - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Bausch Health Cos Inc. (NYSE:BHC) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER S - GuruFocus
Analysts Are Optimistic We'll See A Profit From Bausch Health Companies Inc. (NYSE:BHC) - 富途牛牛
Six students with skin conditions can get up to $10,000 each - Stock Titan
Bausch Health unit moves to settle charges it misled investors -SEC - AOL.com
Death Cross: Is Bausch Health Companies Inc impacted by rising ratesEarnings Recap Report & Technical Buy Zone Confirmations - baoquankhu1.vn
Is the Options Market Signaling a Surge for Bausch Health Shares? - Bitget
Is the Options Market Predicting a Spike in Bausch Health Stock? - Zacks Investment Research
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):